Malta - English - Medicines Authority

tillotts pharma uk ltd wellingore hall, wellingore lincolnshire, ln5 0hx, united kingdom - budesonide - hard capsule - budesonide 3 milligram(s) - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tillotts pharma gmbh, germany - fidaxomicin - film-coated tablet - 200 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - budesonide - modified-release capsule - 3mg

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - mesalazine 400mg - enteric coated tablet - 400 mg - active: mesalazine 400mg excipient: iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc   sodium starch glycolate triethyl citrate - induction of remission of mild to moderate episodes of ulcerative colitis. maintenance of remission of ulcerative colitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - mesalazine 800mg - enteric coated tablet - 800 mg - active: mesalazine 800mg excipient: iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc   sodium starch glycolate triethyl citrate - ulcerative colitis: induction of remission of mild to moderate episodes. maintenance of remission.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesalazine 800mg - enteric coated tablet - 800 mg - active: mesalazine 800mg excipient: dibutyl phthalate iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc   sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - mesalazine 16.67%{relative} - suppository - 16.67% w/w - active: mesalazine 16.67%{relative} excipient: hard fat

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - mesalazine - gastro-resistant tablet - 400 milligram(s) - aminosalicylic acid and similar agents; mesalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - mesalazine - gastro-resistant tablet - 800 milligram(s) - aminosalicylic acid and similar agents; mesalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - mesalazine - gastro-resistant tablet - 400 milligram(s) - aminosalicylic acid and similar agents; mesalazine